Handelsbanken Fonder
BIO icon

Handelsbanken Fonder’s Bio-Rad Laboratories Class A BIO Stock Holding History

Handelsbanken Fonder’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Hold
6,332
– – 0.01% 838
2026
Q1 		$1.76M Hold
6,332
– – 0.01% 792
2025
Q4 		$1.92M Buy
6,332
+760
+14% +$237K 0.01% 751
2025
Q3 		$1.56M Hold
5,572
– – 0.01% 823
2025
Q2 		$1.34M Sell
5,572
-100
-2% -$23.6K ﹤0.01% 823
2025
Q1 		$1.38M Hold
5,672
– – 0.01% 808
2024
Q4 		$1.86M Buy
5,672
+400
+8% +$136K 0.01% 703
2024
Q3 		$1.76M Buy
5,272
+900
+21% +$286K 0.01% 711
2024
Q2 		$1.19M Hold
4,372
– – 0.01% 759
2024
Q1 		$1.51M Hold
4,372
– – 0.01% 686
2023
Q4 		$1.41M Hold
4,372
– – 0.01% 664
2023
Q3 		$1.57M Hold
4,372
– – 0.01% 595
2023
Q2 		$1.66M Sell
4,372
-200
-4% -$81.4K 0.01% 580
2023
Q1 		$2.19M Buy
4,572
+1,500
+49% +$702K 0.01% 519
2022
Q4 		$1.29M Hold
3,072
– – 0.01% 588
2022
Q3 		$1.28M Hold
3,072
– – 0.01% 591
2022
Q2 		$1.52M Sell
3,072
-400
-12% -$208K 0.01% 579
2022
Q1 		$1.96M Hold
3,472
– – 0.01% 587
2021
Q4 		$2.62M Sell
3,472
-400
-10% -$299K 0.01% 564
2021
Q3 		$2.89M Buy
3,872
+400
+12% +$300K 0.02% 559
2021
Q2 		$2.24M Sell
3,472
-300
-8% -$183K 0.01% 606
2021
Q1 		$2.15M Hold
3,772
– – 0.01% 591
2020
Q4 		$2.2M Buy
3,772
+500
+15% +$285K 0.01% 591
2020
Q3 		$1.69M Buy
3,272
+200
+7% +$101K 0.01% 594
2020
Q2 		$1.39M Buy
+3,072
New +$1.36M 0.01% 602

Other funds holding BIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
AL
Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Handelsbanken Fonder's BIO Position: Q2 2026 in Review

Handelsbanken Fonder held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 6,332 shares worth $1.86M. The position accounts for 0.01% of the portfolio, ranked #838.

Handelsbanken Fonder first reported a position in BIO in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.89M in Q3 2021. 133 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Handelsbanken Fonder held 6,332 shares of Bio-Rad Laboratories Class A worth $1.86M as of Q2 2026.
  • Handelsbanken Fonder left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #838 holding.
  • Handelsbanken Fonder first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and has held it in 25 quarters since.
  • Handelsbanken Fonder's Bio-Rad Laboratories Class A position peaked at $2.89M in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.